CN111592533B - 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof - Google Patents

1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof Download PDF

Info

Publication number
CN111592533B
CN111592533B CN202010548717.5A CN202010548717A CN111592533B CN 111592533 B CN111592533 B CN 111592533B CN 202010548717 A CN202010548717 A CN 202010548717A CN 111592533 B CN111592533 B CN 111592533B
Authority
CN
China
Prior art keywords
oxadiazole
formula
bipyridyl
compound
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010548717.5A
Other languages
Chinese (zh)
Other versions
CN111592533A (en
Inventor
谭成侠
邹文倩
杨森
戴立
田晓雨
任朝丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN202010548717.5A priority Critical patent/CN111592533B/en
Publication of CN111592533A publication Critical patent/CN111592533A/en
Application granted granted Critical
Publication of CN111592533B publication Critical patent/CN111592533B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention belongs to the technical field of chemical synthesis and drug application, and particularly relates to a 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and a preparation method and application thereof. The invention generates 5-iodine-2-chlorobenzoic acid methyl ester by 5-iodine-2-chlorobenzoic acid and methanol, the product reacts with cuprous cyanide to generate 2-chlorine-5-cyano methyl benzoate, the obtained product reacts with hydroxylamine hydrochloride and 3, 6-dichloropicolinic acid in sequence, and then hydrolyzes and condenses to obtain the 1,2, 4-oxadiazole bipyridyl substituted benzamide compounds, the preparation method is simple and the operation is convenient, the structure of the obtained product is confirmed by nuclear magnetic hydrogen spectrum, 14 obtained target products are tested for bactericidal activity, and the result shows that: the target product of the invention shows better inhibition to sclerotinia rot of colza, gray mold of cucumber and rice sheath blight disease under the concentration of 50ppm, and the inhibition rate of some compounds is up to more than 80%.

Description

1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof
Technical Field
The invention belongs to the fields of chemical synthesis and drug application, and particularly relates to a 1,2, 4-oxadiazole bipyridyl substituted benzamide compound as well as a preparation method and application thereof.
Background
With the improvement of living standard, people have more and more urgent requirements on low-degree, environment-friendly and pollution-free pesticides, so that the development of pesticides with low toxicity, high efficiency, low residue and environmental friendliness is a necessary trend for the development of new pesticides. Heterocyclic compounds are important in the research and development of new pesticides. Both natural and synthetic heterocyclic compounds play important roles in medicines and pesticides. In the heterocyclic compound, the 1,2, 4-oxadiazole derivative containing nitrogen and oxygen atoms is important, and the 1,2, 4-oxadiazole derivative has biological activities such as insect killing, mite killing, sterilization, weeding and the like due to the unique structure. In addition, the amide compound is widely applied to the fields of pesticides and medicines, shows good biological activities such as bacteriostasis, weeding, disinsection, antivirus and the like, and is one of hot spots for creating new pesticides through synthesis and activity research.
Disclosure of Invention
Aiming at the problems in the prior art, the invention aims to provide a preparation method and application of a 1,2, 4-oxadiazole bipyridyl substituted benzamide compound.
The 1,2, 4-oxadiazole bipyridyl substituted benzamide compound is characterized in that the structural formula is shown as a formula (7):
Figure BDA0002541702670000021
in the formula (7), H on a benzene ring is mono-substituted or multi-substituted by substituent groups, and the mono-substituted or multi-substituted substituent groups R are respectively and independently selected from H, alkyl, substituted alkyl and halogen.
The 1,2, 4-oxadiazole bipyridyl substituted benzamide compound is characterized in that substituents are H, C independently1~C4Alkyl of (C)1~C4F, Cl or Br.
The 1,2, 4-oxadiazole bipyridyl substituted benzamide compound is characterized in that R in the formula (7) is H, 2-methyl, 3-methyl, 4-tert-butyl, 2, 4-dimethyl, 3-trifluoromethyl, 2-fluoro, 3-fluoro, 4-fluoro, 2-chloro, 3-chloro, 4-chloro or 4-bromo.
The preparation method of the 1,2, 4-oxadiazole bipyridyl substituted benzamide compound is characterized by comprising the following steps:
1) adding 5-iodine-2-chlorobenzoic acid shown in a formula (1) into methanol, and carrying out esterification reaction under the catalysis of concentrated sulfuric acid to generate 5-iodine-2-chlorobenzoic acid methyl ester shown in a formula (2);
2) using DMF as a solvent, and reacting the 5-iodo-2-chlorobenzoic acid methyl ester obtained in the step 1) with cuprous cyanide under the catalysis of L-proline to generate 2-chloro-5-cyanobenzoic acid methyl ester shown in a formula (3);
3) using ethanol as a solvent, and reacting the methyl 2-chloro-5-cyanobenzoate obtained in the step 2) with hydroxylamine hydrochloride to generate a compound 4 shown in a formula (4);
4) cyclizing the compound 4 obtained in the step 3) and 3, 6-dichloropicolinic acid by taking toluene as a solvent to generate a compound 5 shown in a formula (5);
5) hydrolyzing the compound 5 obtained in the step 4) under an alkaline condition to generate a compound 6 shown in a formula (6), and carrying out a condensation reaction on the compound 6 and substituted aniline by using EDC & HCl as a condensing agent to obtain a 1,2, 4-oxadiazole bipyridyl substituted benzamide compound shown in the formula (I);
the reaction process is as follows:
Figure BDA0002541702670000031
the preparation method of the 1,2, 4-oxadiazole bipyridyl substituted benzamide compound is characterized in that in the step 2), the molar ratio of the 5-iodine-2-methyl chlorobenzoate to the cuprous cyanide is 1: 1.5.
The preparation method of the 1,2, 4-oxadiazole bipyridyl substituted benzamide compound is characterized in that in the step 2), the reaction is carried out in two stages, the stirring is carried out for 1-3 hours at 70-80 ℃, and then the temperature is raised to 100 ℃ for reaction for 7-8 hours.
The preparation method of the 1,2, 4-oxadiazole bipyridyl substituted benzamide compound is characterized in that in the step 3), the molar ratio of the 2-chloro-5-cyanobenzoic acid methyl ester to the hydroxylamine hydrochloride is 1: 1.1.
The preparation method of the 1,2, 4-oxadiazole bipyridyl substituted benzamide compound is characterized in that in the step 5), the compound 6 is dissolved in dichloromethane at normal temperature, the temperature is reduced to 4-6 ℃, substituted aniline and EDC & HCl are added, and ice bath reaction is continued for 7-9 hours.
The 1,2, 4-oxadiazole bipyridyl substituted benzamide compound is applied as a bactericide.
The invention provides a 1,2, 4-oxadiazole bipyridyl substituted benzamide compound, which has the advantages of simple preparation method and convenient operation, the structure is confirmed by nuclear magnetic hydrogen spectrum, 14 obtained target products are tested for bactericidal activity, and the result shows that: the target product of the invention shows better inhibition to sclerotinia rot of colza, gray mold of cucumber and rice sheath blight disease under the concentration of 50ppm, and the inhibition rate of some compounds is up to more than 80%.
Detailed Description
The present invention is further illustrated by the following examples, which should not be construed as limiting the scope of the invention.
Example 1 preparation of methyl 5-iodo-2-chlorobenzoate represented by formula (2):
50mL of methanol, 2.8g (0.01mol) of 5-iodo-2-chlorobenzoic acid and 0.2mL of concentrated sulfuric acid are respectively added into a 100mL three-neck flask, reflux reaction is carried out, TLC (thin layer chromatography) is used for tracking and monitoring an experiment, the reaction is finished for about 8h, when a reaction solution is cooled to room temperature, rotary evaporation is carried out for desolventizing, ethyl acetate is added, the pH value of the system is adjusted to 7-8 by using a sodium carbonate aqueous solution, an organic layer is taken, and drying and desolventizing are carried out to obtain 2.7g of beige solid, wherein the: 92.1 percent and m.p.40-42 ℃;
1H NMR(500MHz,Chloroform-d)δ8.14(d,J=2.0Hz,1H),7.72(dd,J=8.5,2.5Hz,1H),7.19(d,J=8.0Hz,1H),3.94(s,3H).
example 2 preparation of methyl 2-chloro-5-cyanobenzoate represented by formula (3):
adding (1.3mmol) of methyl 5-iodo-2-chlorobenzoate obtained in example 1, (2.0mmol) cuprous cyanide, (1.3mmol) L-proline and 15mL DMF into a 100mL three-necked flask, dissolving, heating to 75 ℃, reacting for two hours, heating to 100 ℃, continuing to react, monitoring the reaction by a TLC method, cooling the reaction solution after about 8 hours of reaction is finished, filtering to remove filter residues, adding 100mL of water and 100mL of ethyl acetate into the filtrate respectively, extracting the organic phase by anhydrous magnesium sulfate, and removing the ethyl acetate by rotary evaporation to obtain 0.2g of yellow solid, wherein the yield is as follows: 79.3 percent and m.p.102-105 ℃;
1H NMR(500MHz,Chloroform-d)δ8.15(d,J=2.0Hz,1H),7.70(dd,J=8.5,2.5Hz,1H),7.60(d,J=8.5Hz,1H),3.98(s,3H).
example 3 preparation of compound 4 represented by formula (4):
1.4g (7.2mmol) of methyl 2-chloro-5-cyanobenzoate obtained in example 2 was weighed into a three-necked flask, 0.55g of hydroxylamine hydrochloride was added and dissolved in 45mL of ethanol, mechanical stirring was turned on at room temperature, then 1.1g of triethylamine was added dropwise, the reaction was completed in 10min, the reaction was started, the progress of the reaction was monitored by Thin Layer Chromatography (TLC), the reaction was allowed to proceed for 2 hours, the solution was removed by rotary evaporation, the residue was dissolved in ethyl acetate and saturated saline, and the mixture was poured into a separatory funnel and allowed to stand for separation, and the organic layer was retained. Adding anhydrous sodium sulfate into the organic phase to remove water, performing rotary evaporation to remove the solvent, and purifying by column chromatography to obtain a light yellow solid with the weight of 1.5g and the yield: 90.4 percent, m.p.108-111 ℃;
1H NMR(500MHz,DMSO-d6)δ9.87(s,1H),8.13(d,J=2.0Hz,1H),7.85(dd,J=8.5,2.0Hz,1H),7.59(d,J=8.5Hz,1H),5.98(s,2H),3.87(s,3H).
example 4 preparation of compound 5 represented by formula (5):
into a 100mL three-necked flask, 1.1g (5mmol) of 3, 6-dichloropicolinic acid was added followed by 20mL of SOCl2Dissolving, refluxing and stirring at 100 ℃ for 2h, monitoring by TLC that the raw material point basically disappears, and removing thionyl chloride by rotary evaporation to obtain the 3, 6-dichloropicolinic formyl chloride.
A250 mL three-necked flask was charged with 41.1 g (5mmol) of the compound prepared in example 3, 1.2g (5mmol) of triethylamine, and 100mL of anhydrous toluene. Controlling the temperature to be 0 ℃, stirring for reaction for 2 hours, then dropwise adding the prepared 3, 6-dichloropicolinic acid formyl chloride (dissolved in 30mL of anhydrous toluene), continuing stirring for reaction for 3 hours at the temperature of 0 ℃, then heating for reflux reaction, monitoring by TLC, and ending the reaction for about 2 hours. The reaction solution was washed with 150mL of water, then with a saturated sodium chloride solution, the organic phase was added with anhydrous sodium sulfate to remove water, rotary evaporation was performed to remove the solvent, and drying was performed to obtain 1.5g of a product, yield: 78.3 percent and m.p.148-152 ℃;
1H NMR(500MHz,Chloroform-d)δ8.65(d,J=2.0Hz,1H),8.32–8.15(m,1H),7.92(d,J=8.5Hz,1H),7.61(d,J=8.3Hz,1H),7.54(d,J=8.4Hz,1H),3.98(s,3H).
example 5 preparation of compound 6 represented by formula (6):
in a 100mL three-necked flask, the compound obtained in example 5 (2.0mmol) and 40mL of THF were initially charged, and after dissolution, an aqueous solution of sodium hydroxide (5mL) was added, the reaction was refluxed and monitored by TLC, and the reaction was completed in about 2 hours. Removing THF through rotary evaporation, adding 50mL of water for dissolving, adjusting the pH value to 2-3, precipitating a white solid, performing suction filtration and drying to obtain a product compound 6, wherein the yield is as follows: 93.6 percent.1H NMR(500MHz,Chloroform-d)δ13.64(s,1H),8.45(d,J=2.1Hz,1H),8.34(d,J=8.5Hz,1H),8.25–8.17(m,1H),7.91(d,J=8.6Hz,1H),7.80(d,J=8.3Hz,1H).
Examples 6-19 preparation of the target product I:
after dissolving compound 6 (3.3mmol) obtained in example 5 and 15mL of dichloromethane in a 50mL three-neck flask, cooling to 5 ℃ in an ice bath, adding (2.3mmol) of EDC · HCl, dropwise adding substituted aniline (2.1mmol) while stirring, continuing the reaction in the ice bath after the dropwise addition, and monitoring the reaction by TLC method (the ratio of developing solvent is Ea: Pe ═ 1:3, two drops of triethylamine are added dropwise to 4mL of developing solvent), and the reaction is completed for about 8 hours. Removing dichloromethane by rotary evaporation to obtain brown viscous solid, dissolving with 10mL anhydrous ethanol under stirring, adding prepared 3% diluted hydrochloric acid solution under ice bath condition, adjusting pH to 7-8, adding anhydrous ethanol in ice water bath, stirring for 30min until the system is just clear, continuously precipitating cement color solid, and washing with ethanol-water mixed solution (V)Ethanol:VWater (W)1) and filtering, drying to obtain cement-colored solids, namely target products I-1 to I-14, wherein the specific data are shown in tables 1 and 2.
TABLE 11, 2, 4-oxadiazole bipyridyl substituted benzamides data
Figure BDA0002541702670000071
TABLE 21, 2, 4-oxadiazole bipyridyl substituted benzamides data of hydrogen spectra
Figure BDA0002541702670000072
Figure BDA0002541702670000081
Figure BDA0002541702670000091
Example 20 bactericidal Activity test
1 test sample:
the test subjects include Botrytis cinerea (Botrytis cinerea), Sclerotinia sclerotiorum (Sclerotinia sclerotiorum), Rhizoctonia solani (Thanatephora cupricis), Cucumis sativus (Fusarium oxysporum), Pseudocercospora arachidicola (Cercospora arachidicola), and Phyllospora malorum (Borgyposea berengiana).
Test treatment, namely dissolving the compound shown in the formula (I) into 1% EC by DMF for standby, evaluating the indoor bactericidal activity of the test compound on 6 test targets under the dosage of 50mg/L by adopting a hypha growth inhibition method, wherein the activity test result is shown in Table 3;
TABLE 31, 2, 4-oxadiazole bipyridyl substituted benzamides compound bactericidal activity
Figure BDA0002541702670000092
The bactericidal activity results of 14 bactericidal activity results containing 1,2, 4-oxadiazole bipyridyl substituted benzamide compounds (table 3) show that 14 samples have certain inhibitory activity to 6 targets under the dosage of 50ppm, especially the compound I-5, has the inhibition rate of more than 80% on sclerotinia rot of colza, gray mold of cucumber and rice sheath blight, is superior to that of a control medicament, and provides a thought for further optimization of the structure later.
The description is given for the sole purpose of illustrating embodiments of the inventive concept and should not be taken as limiting the scope of the invention to the particular forms set forth in the embodiments, but rather as being limited only to the equivalents thereof as may be contemplated by those skilled in the art based on the teachings herein.

Claims (7)

1,2, 4-oxadiazole bipyridyl substituted benzamide compounds, which are characterized in that the structural formula is shown as formula (7):
Figure FDA0003080511780000011
in the formula (7), H on the benzene ring at the rightmost end is mono-substituted or multi-substituted by substituent, and the mono-substituted or multi-substituted substituent R is H, 2-methyl, 3-methyl, 4-tertiary butyl, 2, 4-dimethyl, 3-trifluoromethyl, 2-fluorine, 3-fluorine, 4-fluorine, 2-chlorine, 3-chlorine, 4-chlorine or 4-bromine.
2. A method for producing a 1,2, 4-oxadiazole-bipyridyl-substituted benzamide compound according to claim 1, which comprises the steps of:
1) adding 5-iodine-2-chlorobenzoic acid shown in a formula (1) into methanol, and carrying out esterification reaction under the catalysis of concentrated sulfuric acid to generate 5-iodine-2-chlorobenzoic acid methyl ester shown in a formula (2);
2) using DMF as a solvent, and reacting the 5-iodo-2-chlorobenzoic acid methyl ester obtained in the step 1) with cuprous cyanide under the catalysis of L-proline to generate 2-chloro-5-cyanobenzoic acid methyl ester shown in a formula (3);
3) using ethanol as a solvent, and reacting the methyl 2-chloro-5-cyanobenzoate obtained in the step 2) with hydroxylamine hydrochloride to generate a compound 4 shown in a formula (4);
4) cyclizing the compound 4 obtained in the step 3) and 3, 6-dichloropicolinic acid by taking toluene as a solvent to generate a compound 5 shown in a formula (5);
5) hydrolyzing the compound 5 obtained in the step 4) under an alkaline condition to generate a compound 6 shown in a formula (6), and carrying out a condensation reaction on the compound 6 and substituted aniline by using EDC & HCl as a condensing agent to obtain a 1,2, 4-oxadiazole bipyridyl substituted benzamide compound shown in the formula (I);
the reaction process is as follows:
Figure FDA0003080511780000021
3. the preparation method of the 1,2, 4-oxadiazole bipyridyl substituted benzamide compound according to claim 2, wherein the molar ratio of methyl 5-iodo-2-chlorobenzoate to cuprous cyanide in step 2) is 1: 1.5.
4. The method for preparing the 1,2, 4-oxadiazole bipyridyl substituted benzamide compound according to claim 2, wherein the reaction in step 2) is carried out in two stages, the mixture is stirred for 1-3 hours at 70-80 ℃, and then heated to 100 ℃ for reaction for 7-8 hours.
5. The method for preparing 1,2, 4-oxadiazole bipyridyl substituted benzamide compound according to claim 2, wherein the molar ratio of methyl 2-chloro-5-cyanobenzoate to hydroxylamine hydrochloride in step 3) is 1: 1.1.
6. The preparation method of the 1,2, 4-oxadiazole bipyridyl substituted benzamide compound according to claim 2, wherein in step 5), the compound 6 is dissolved in dichloromethane at normal temperature, the temperature is reduced to 4-6 ℃, substituted aniline and EDC & HCl are added, and ice bath reaction is continued for 7-9 h.
7. Use of the 1,2, 4-oxadiazole bipyridyl substituted benzamide compound according to claim 1 for preparing a fungicide.
CN202010548717.5A 2020-06-16 2020-06-16 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof Active CN111592533B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010548717.5A CN111592533B (en) 2020-06-16 2020-06-16 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010548717.5A CN111592533B (en) 2020-06-16 2020-06-16 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN111592533A CN111592533A (en) 2020-08-28
CN111592533B true CN111592533B (en) 2021-08-24

Family

ID=72184352

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010548717.5A Active CN111592533B (en) 2020-06-16 2020-06-16 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN111592533B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112979627B (en) * 2021-03-08 2023-08-22 浙江工业大学 Pyrazole bi-1, 2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof
CN114656461B (en) * 2022-04-26 2024-01-30 浙江工业大学 Quinoline ring-containing 1,2, 4-oxadiazole substituted benzamide compound and synthetic method and application thereof
CN114920734A (en) * 2022-06-02 2022-08-19 浙江工业大学 5- (pyrazole-5-yl) -1,2, 4-oxadiazole substituted benzamide compounds and preparation method and application thereof
CN114920736B (en) * 2022-06-02 2024-01-30 浙江工业大学 Quinoline ring-containing 1,2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1138858A (en) * 1994-01-17 1996-12-25 拜尔公司 1,2,4-oxadiazole derivatives and their use as parasiticides for animals
CN101801958A (en) * 2007-07-19 2010-08-11 先灵公司 Heterocyclic amide as protein kinase inhibitors
CN103539784A (en) * 2012-07-09 2014-01-29 中国科学院广州生物医药与健康研究院 Heterocyclic benzamide compounds, pharmaceutical compositions as well as application thereof
CN106231905A (en) * 2014-04-24 2016-12-14 住友化学株式会社 Diaryl azole compounds
CN108347935A (en) * 2015-11-05 2018-07-31 巴斯夫欧洲公司 Qu Dai oxadiazole classes for preventing plant pathogenic fungi
CN109068652A (en) * 2016-04-08 2018-12-21 先正达参股股份有限公司 Kill the oxadiazole derivatives of microorganism
WO2019122323A1 (en) * 2017-12-22 2019-06-27 Bayer Aktiengesellschaft Fungicidal oxadiazoles
WO2019150219A2 (en) * 2018-01-30 2019-08-08 Pi Industries Ltd. Novel oxadiazoles

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1138858A (en) * 1994-01-17 1996-12-25 拜尔公司 1,2,4-oxadiazole derivatives and their use as parasiticides for animals
CN101801958A (en) * 2007-07-19 2010-08-11 先灵公司 Heterocyclic amide as protein kinase inhibitors
CN103539784A (en) * 2012-07-09 2014-01-29 中国科学院广州生物医药与健康研究院 Heterocyclic benzamide compounds, pharmaceutical compositions as well as application thereof
CN106231905A (en) * 2014-04-24 2016-12-14 住友化学株式会社 Diaryl azole compounds
CN108347935A (en) * 2015-11-05 2018-07-31 巴斯夫欧洲公司 Qu Dai oxadiazole classes for preventing plant pathogenic fungi
CN109068652A (en) * 2016-04-08 2018-12-21 先正达参股股份有限公司 Kill the oxadiazole derivatives of microorganism
WO2019122323A1 (en) * 2017-12-22 2019-06-27 Bayer Aktiengesellschaft Fungicidal oxadiazoles
WO2019150219A2 (en) * 2018-01-30 2019-08-08 Pi Industries Ltd. Novel oxadiazoles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Discovery of 4-chloro-3-(5-(pyridin-3-yl)-1,2,4-oxadiazole-3-yl) benzamides as novel RET kinase inhibitors;Mei Han,等;《Bioorganic & Medicinal Chemistry Letters》;20161024;第26卷;第5679-5684页 *

Also Published As

Publication number Publication date
CN111592533A (en) 2020-08-28

Similar Documents

Publication Publication Date Title
CN111592533B (en) 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof
CN111943944B (en) Ethylthio-containing pyridine-bis-1, 2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof
AU2013272007B2 (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
CN112062759B (en) Ethylsulfonyl-containing pyridine-1, 2, 4-oxadiazole substituted benzamide compounds and preparation method and application thereof
CN104610250A (en) 1,2,3-thiadiazole-5-formamidine compound containing three N-heterocycles and synthesis
CN112979627B (en) Pyrazole bi-1, 2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof
CN115232008B (en) Compound, preparation method thereof and application of compound in preparation of fluroxypyr intermediate
CN105566237B (en) A kind of preparation method for the triazole mercapto phenylacetic acid compound for treating gout
CN102001979A (en) Preparation method of 2-(2', 2'-difluoroethoxyl)-6-trifluoromethyl phenyl propyl sulfide
CN115260175A (en) 5- (pyrazole-5-yl) -1,2,4-oxadiazole substituted benzamide compound and preparation method and application thereof
CN115260174A (en) 5- (pyrazole-4-yl) -1,2, 4-oxadiazole substituted benzamide compounds and preparation method and application thereof
JP2524491B2 (en) Novel aminocarboxylic acid ester and process for producing the same
CN114656461B (en) Quinoline ring-containing 1,2, 4-oxadiazole substituted benzamide compound and synthetic method and application thereof
CN111747879A (en) Large-process synthesis method of erexib
KR101554539B1 (en) Development of Method for Amide Bond Formation via Metal-Free Aerobic Oxidative Amination of Aldehydes
CN114716451B (en) Frutinone compound and preparation method and application thereof
AU2023219866A1 (en) Compound, Preparation Method Therefor and Application of Compound in Preparation of Bicyclopyrone Intermediate
CN114920734A (en) 5- (pyrazole-5-yl) -1,2, 4-oxadiazole substituted benzamide compounds and preparation method and application thereof
CN115286622A (en) Quinoline ring-containing 1,2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof
CN114920736A (en) Quinoline ring-containing 1,2, 4-oxadiazole-substituted benzamide compound and preparation method and application thereof
JP2809483B2 (en) 6-Indolizinecarboxamide derivatives, intermediates thereof, methods for their preparation and herbicides
JP3918468B2 (en) 3,3-bis (alkoxycarbonyl-methylthio) propionitrile and process for producing the same
JP2809481B2 (en) 2-Alkoxycarbonyl-3-pyridinecarboxylic acid derivatives, their production and herbicides
KR100902236B1 (en) Phenethyl benzoate derivatives and process for preparing the same
CN117720460A (en) Quinoline compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant